Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04534946 · ClinicalTrials.gov registry record

A Pilot Study Evaluating the Usability of the Oabi Mobile Application

A clinical trial of Overactive Bladder, sponsored by Massachusetts General Hospital.

Completed
Registry status
35
Enrollment target
1
Study location

NCT04534946: Completed study of Overactive Bladder, sponsored by Massachusetts General Hospital.

NCT04534946 is a study of Overactive Bladder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants, below the 211-participant average among 45 other Overactive Bladder trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04534946, a study of Overactive Bladder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

Our primary purpose is to assess the use feasibility and acceptability of the study phone app called, "Oabi" app with patients diagnosed with overactive bladder disorder (OAB).

Conditions Studied

Interventions

  • OTHER This is not an intervention study

Study Locations (1)

Massachusetts

  • Mass General/North Shore Center - Salem

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2017-03-20
Est. Completion 2019-12-31

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04534946

The ClinicalTrials.gov registry entry for NCT04534946 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 211-participant average among 45 other Overactive Bladder trials with a reported enrollment target (83% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which This is not an intervention study is the first listed.

NCT04534946 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04534946 about?

NCT04534946 is a clinical study titled "A Pilot Study Evaluating the Usability of the Oabi Mobile Application". Our primary purpose is to assess the use feasibility and acceptability of the study phone app called, "Oabi" app with patients diagnosed with overactive bladder disorder (OAB).

What is the current status of trial NCT04534946?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2017-03-20. Estimated completion is 2019-12-31.

What conditions does trial NCT04534946 study?

This clinical trial studies the following conditions: Overactive Bladder.

What interventions are being tested in trial NCT04534946?

The interventions under investigation include: This is not an intervention study (OTHER).

Who is sponsoring clinical trial NCT04534946?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04534946 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.